Amyloid-β Peptides Activate α1-Adrenergic Cardiovascular Receptors

被引:30
作者
Haase, Nadine [1 ]
Herse, Florian [1 ]
Spallek, Bastian [1 ]
Haase, Hannelore [2 ]
Morano, Ingo [2 ]
Qadri, Fatimunnisa [1 ]
Szijarto, Istvan A. [1 ]
Rohm, Ilonka [4 ]
Yilmaz, Atilla [4 ]
Warrington, Junie P. [5 ]
Ryan, Michael J. [5 ]
Gollasch, Maik [1 ]
Mueller, Dominik N. [1 ]
Dechend, Ralf [1 ,3 ]
Wallukat, Gerd [1 ]
机构
[1] Expt & Clin Res Ctr, D-13125 Berlin, Germany
[2] Max Delbrueck Ctr Mol Med, Berlin, Germany
[3] HELIOS Klin, Dept Cardiol & Nephrol, Berlin, Germany
[4] Jena Univ Hosp, Dept Cardiol, Jena, Germany
[5] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
关键词
alpha 1-adrenergic receptor; Alzheimer disease; amyloid-; peptides; hypertension; signal transduction; vasoconstriction; MIDLIFE BLOOD-PRESSURE; ALZHEIMERS-DISEASE; BRAIN; CONFORMATIONS; VASOACTIVITY; RISK;
D O I
10.1161/HYPERTENSIONAHA.113.01348
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Alzheimer disease features amyloid- (A) peptide deposition in brain and blood vessels and is associated with hypertension. A peptide can cause vasoconstriction and endothelial dysfunction. We observed that A peptides exert a chronotropic effect in neonatal cardiomyocytes, similar to (1)-adrenergic receptor autoantibodies that we described earlier. Recently, it was shown that (1)-adrenergic receptor could impair blood-brain flow. We hypothesized that A peptides might elicit a signal transduction pathway in vascular cells, induced by (1)-adrenergic receptor activation. A (25-35) and A (10-35) induced a positive chronotropic effect in the cardiac contraction assay (28.75 +/- 1.15 and 29.40 +/- 0.98 bpm), which was attenuated by (1)-adrenergic receptor blockers (urapidil, 1.53 +/- 1.17 bpm; prazosin, 0.30 +/- 0.96 bpm). Both A peptides induced an intracellular calcium release in vascular smooth muscle cells. Chronotropic activity and calcium response elicited by A (25-35) were blocked with peptides corresponding to the first extracellular loop of the (1)-adrenergic receptor. We observed an induction of extracellular-regulated kinase 1/2 phosphorylation by A (25-35) in Chinese hamster ovary cells overexpressing (1)-adrenergic receptor, vascular smooth muscle cells, and cardiomyocytes. We generated an activation-state-sensitive (1)-adrenergic receptor antibody and visualized activation of the (1)-adrenergic receptor by A peptide. A (25-35) induced vasoconstriction of mouse aortic rings and in coronary arteries in Langendorff-perfused rat hearts that resulted in decreased coronary flow. Both effects could be reversed by (1)-adrenergic receptor blockade. Our data are relevant to the association between Alzheimer disease and hypertension. They may explain impairment of vascular responses by A and could have therapeutic implications.
引用
收藏
页码:966 / 972
页数:7
相关论文
共 31 条
[1]   Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature [J].
Carnevale, Daniela ;
Mascio, Giada ;
D'Andrea, Ivana ;
Fardella, Valentina ;
Bell, Robert D. ;
Branchi, Igor ;
Pallante, Fabio ;
Zlokovic, Berislav ;
Yan, Shirley ShiDu ;
Lembo, Giuseppe .
HYPERTENSION, 2012, 60 (01) :188-197
[2]   Role of neuroinflammation in hypertension-induced brain amyloid pathology [J].
Carnevale, Daniela ;
Mascio, Giada ;
Ajmone-Cat, Maria Antonietta ;
D'Andrea, Ivana ;
Cifelli, Giuseppe ;
Madonna, Michele ;
Cocozza, Germana ;
Frati, Alessandro ;
Carullo, Pierluigi ;
Carnevale, Lorenzo ;
Alleva, Enrico ;
Branchi, Igor ;
Lembo, Giuseppe ;
Minghetti, Luisa .
NEUROBIOLOGY OF AGING, 2012, 33 (01) :205.e19-205.e29
[3]   The protective effect of K+ channel openers on β-amyloid induced cerebrovascular endothelial dysfunction [J].
Chi, XD ;
Sutton, ET ;
Thomas, T ;
Price, JM .
NEUROLOGICAL RESEARCH, 1999, 21 (04) :345-351
[4]   The many faces of amyloid β in Alzheimer's disease [J].
Chiang, Peter K. ;
Lam, Michael A. ;
Luo, Yuan .
CURRENT MOLECULAR MEDICINE, 2008, 8 (06) :580-584
[5]   Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics [J].
de la Torre, JC .
LANCET NEUROLOGY, 2004, 3 (03) :184-190
[6]  
De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196
[7]   Midlife Blood Pressure, Amyloid-β, and Risk for Alzheimer Disease One More Reason to Treat Hypertension [J].
Elias, Merrill F. ;
Davey, Adam .
HYPERTENSION, 2012, 59 (04) :771-772
[8]   Adiponectin is a novel humoral vasodilator [J].
Fesues, Gabor ;
Dubrovska, Galyna ;
Gorzelniak, Kerstin ;
Kluge, Reinhart ;
Huang, Yu ;
Luft, Friedrich C. ;
Gollasch, Maik .
CARDIOVASCULAR RESEARCH, 2007, 75 (04) :719-727
[9]   Conformation state-sensitive antibodies to G-protein-coupled receptors [J].
Gupta, Achla ;
Decaillot, Fabien M. ;
Gomes, Ivone ;
Tkalych, Oleg ;
Heimann, Andrea S. ;
Ferro, Erner S. ;
Devi, Lakshmi A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5116-5124
[10]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356